SCHEMBL7533955

SCHEMBL7533955

O=c1nccnc2c1sc1ccccc12

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 1/20 0.51
▸ CDK5 Q00535 1/20 0.51
▸ CDK5R1 Q15078 1/20 0.51
▸ KRAS P01116 1/20 0.47
▸ MIF P14174 1/20 0.44
▸ GABRA1 P14867 1/20 0.44
▸ EGFR P00533 4/20 0.43
▸ HTR2C P28335 1/20 0.41
▸ HRH4 Q9H3N8 1/20 0.41
▸ TNKS O95271 2/20 0.40
▸ TNKS2 Q9H2K2 2/20 0.40
▸ PIM1 P11309 1/20 0.40
▸ PIM2 Q9P1W9 1/20 0.40
▸ PIK3CA P42336 1/20 0.40
▸ GPR3 P46089 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22874230 0.78 LIMK1 (0.54) LIMK1CDK5CDK5R1KRASEGFR
SCHEMBL13209223 0.75 LIMK1 (0.51) LIMK1CDK5CDK5R1KRASEGFR
SCHEMBL16693325 0.75 LIMK1 (0.51) LIMK1CDK5CDK5R1KRASEGFR
SCHEMBL19937109 0.75 LIMK1 (0.51) LIMK1CDK5CDK5R1KRASEGFR
SCHEMBL16685432 0.75 LIMK1 (0.51) LIMK1CDK5CDK5R1KRASEGFR
SCHEMBL29519419 0.75 LIMK1 (0.51) LIMK1CDK5CDK5R1KRASEGFR
SCHEMBL16283936 0.75 LIMK1 (0.47) LIMK1CDK5CDK5R1KRASEGFR
SCHEMBL30179985 0.73 CDK1 (0.44) LIMK1KRASMIFGABRA1MEN1
SCHEMBL15374732 0.73 GPR3 (0.46) LIMK1CDK5CDK5R1KRASMIF
SCHEMBL24589835 0.72 LIMK1 (0.49) LIMK1CDK5CDK5R1KRASEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002014324-A2 DIAZEPINONES AS ANTIVIRAL AGENTS WARNER-LAMBERT COMPANY (US) 2002-02-21 — — WO claimed
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 — — US disclosed
Send feedback